Identifying drugs with disease‐modifying potential in Parkinson’s disease using artificial intelligence and pharmacoepidemiology

May 2020 
Journal: Pharmacoepidemiology & Drug Safety
Lead Authors: Laura C. Maclagan, Naomi P. Visanji
All Authors: Laura C. Maclagan, Naomi P. Visanji, Yi Cheng, Mina Tadrous, Alix M.B. Lacoste, Lorraine V. Kalia, Susan E. Bronskill, Connie Marras


ONDRI Aim 4 infographic on parkinson's disease study

Researchers used artificial intelligence paired with real-world Ontario health data to examine drugs that may prevent or slow Parkinson’s disease. Five drugs were identified that may reduce the risk of Parkinson’s disease. These drugs should be prioritized for future research.